Name: Financial Leverage

Definition: Financial leverage tells you how much borrowed money the company uses to boost its size and profits. Using leverage can help a business grow faster, but it also increases pressure if sales slow down. Moderate leverage is common and often healthy. Excessive leverage can be dangerous, especially during tough economic times.

Interpretation:
• In '2021', RIGL's financial leverage was 5.51, indicating how much debt is used to finance assets. Industry average for Biotechnology: Pharmaceutical Preparations in '2021' stood at 1.45.
• In '2022', RIGL's financial leverage was 18.00, indicating how much debt is used to finance assets. The increase compared to '2021' may signal growing financial pressure. Industry average for Biotechnology: Pharmaceutical Preparations in '2022' stood at 1.54. Industry average increased by 0.08 compared to previous year.
• In '2023', RIGL's financial leverage was -5.95, indicating how much debt is used to finance assets. The decrease since '2022' reflects improving financial health. Industry average for Biotechnology: Pharmaceutical Preparations in '2023' stood at 1.32. Industry average declined by 0.22 from previous year.
• In '2024', RIGL's financial leverage was -11.09, indicating how much debt is used to finance assets. The decrease since '2023' reflects improving financial health. Industry average for Biotechnology: Pharmaceutical Preparations in '2024' stood at 1.51. Industry average increased by 0.19 compared to previous year.
Overall, RIGL's financial leverage has been volatile but showed a downward trend over the past 4 years.

Formula: Financial Leverage = Average Total Assets / Average Shareholders' Equity

Good Range: 1 to 3 common; above 3 may indicate high leverage risk.